Subscribe To Our Free Newsletter |
Lupin launches Mirabegron Extended-Release Tablets in US
Lupin announced the launch of Mirabegron Extended-Release Tablets, 50 mg, in the United States, after having received an approval from the United States Food and Drug Administration (U.S. FDA).